(Q24247773)

2

0 references

Marta Roqué

1

0 references

Pablo Alonso-Coello

3

0 references

author name string

Elena Català

4

0 references

Jose Luis Garcia

5

0 references

Marta Ferrandiz

Cochrane Database of Systematic Reviews

6

0 references

publication date

1 September 1996

0 references

published in

0 references

cites work

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Strontium and samarium therapy for bone metastases from prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Painful bone metastases in hormone-refractory prostate cancer: economic costs of strontium-89 and/or external radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Calcitonin for metastatic bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Palliative therapy with bone seeking radiopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Systemic bone-seeking radionuclides for palliation of painful osseous metastases: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Cancer pain. Epidemiology and syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Strontium 89 therapy for the palliation of pain due to osseous metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

7 January 2021

Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

7 January 2021

A retrospective analysis of the cost effectiveness of treatment with Metastron in patients with prostate cancer metastatic to bone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

7 January 2021

Bone metastases: pathophysiology and management policy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

7 January 2021

Efficacy and safety of nonsteroidal antiinflammatory drugs for cancer pain: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

7 January 2021

Palliation of pain associated with metastatic bone cancer using samarium-153 lexidronam: a double-blind placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003347

7 January 2021